PF1163A and B, New Antifungal Antibiotics Produces by Penicilium sp. II. Physico-chemical Properties and Structure Elucidation
スポンサーリンク
概要
- 論文の詳細を見る
- 2000-01-25
著者
-
USUI Takayuki
Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd.
-
YOSHIDA Shigemi
Exploratory Research Laboratories, Tsukuba Research Institute, Banyu Pharmaceutical Co., Ltd.
-
WATANABE Takashi
Pharmaceutical Research Center, Meiji Seika Kaisha
-
Sasaki Toru
Positron Medical Center Tokyo Metropolitan Institute Of Gerontology
-
Nose H
Meiji Seika Kaisha Ltd. Yokohama Jpn
-
SASAKI Toru
Pharmaceutical Research Center, Meiji Seika, Ltd.
-
NOSE Hiroshi
Pharmaceutical Research Center, Meiji Seika, Ltd.
-
HOSOYA Ayako
Pharmaceutical Research Center, Meiji Seika, Ltd.
-
YOSHIDA Shigemi
Pharmaceutical Research Center, Meiji Seika, Ltd.
-
KAWAGUCHI Mami
Pharmaceutical Research Center, Meiji Seika, Ltd.
-
OHTSUKA Yasuo
Pharmaceutical Research Center, Meiji Seika, Ltd.
-
SHOMURA Takashi
Pharmaceutical Research Center, Meiji Seika, Ltd.
-
TAKANO Satoko
Department of Applied Chemistry, School of Science and Engineering, Waseda University
-
TATSUTA Kuniaki
Department of Applied Chemistry, School of Science and Engineering, Waseda University
-
Hosoya Ayako
Drug Discovery Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
-
Ohtsuka Yasuo
Pharmaceutical Research Center Meiji Seika Ltd.
-
Takano Satoko
Department Of Applied Chemistry School Of Science And Engineering Waseda University
-
Kawaguchi Mami
Pharmaceutical Research Center Meiji Seika Ltd.
-
Tatsuta K
Waseda Univ. Tokyo Jpn
-
Tatsuta Kuniaki
Department Of Applied Chemistry Keio University Hiyoshi
-
Shomura Takashi
Drug Discovery Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
-
Usui Takayuki
Pharmaceutical Research Center Meiji Seika Ltd.
-
Usui Takayuki
Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
-
Tsuchiya Kouichi
Applied Microbiology Research Center Nippon Kayaku Co. Ltd.
-
Tsuchiya Kouichi
Research And Development Division Pharmaceuticals Group Nippon Kayaku Co. Ltd.
-
Sasaki Toru
Drug Discovery Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
-
Tatsuta Kuniaki
Department Of Applied Chemistry Faculty Of Science And Technology Keito University
-
Sasaki Toru
Pharmaceutical Research Center Meiji Seika Kaisha Ltd.
-
Yoshida Shigemi
Exploratory Research Laboratories Tsukuba Research Institute Banyu Pharmaceutical Co. Ltd.
-
Watanabe Takashi
Pharmaceutical Research Center Meiji Seika Kaisha
関連論文
- Low density of sigma_1 receptors in early Alzheimer's disease
- Successive positron emission tomography measurement of cerebral blood flow and neuroreceptors in the human brain : an ^C-SA4503 study
- Low density of sigma_1 receptors in early Alzheimer's disease
- A feasibility study of [^C]SA4503-PET for evaluating sigma_1 receptor occupancy by neuroleptics : the binding of haloperidol to sigma_1 and dopamine D_2-like receptors
- Imaging of adenosine A_1 receptors in the human brain by positron emission tomography with [^C]MPDX
- Intrasubject correlation between static scan and distribution volume images for [^C]flumazenil PET
- Metabolite analysis of [^C]flumazenil in human plasma : Assessment as the standardized value for quantitative PET studies
- Inhibition of Mouse Tumor Metastasis with Nojirimycin-related Compounds
- Synthesis and Activities of Bactobolin Derivatives Based on the Alteration of the Functionality at C-3 Position
- SF2809 Compounds, Novel Chymase Inhibitors from Dactylosporangium sp : 2. Structural Elucidation
- SF2809 Compounds, Novel Chymase Inhibitors from Dactylosporangium sp : 1. Taxonomy, Fermentation, Isolation and Biological Properties
- New Cytotoxic Agents, BE-54238A and B, Produced by a Streptomycete
- Inhibitory Activity of Dome Formation in LLC-PK_1 Cells Is a Selective Index of Aminoglycoside Nephrotoxicity
- TRU-0037-A, B, C and D, Novel Lydicamycin Congeners with Anti-MRSA Activity from Streptomyces platensis TP-A0598
- A New Anthracycline Antibiotic, IT-62-B, Converts the Morphology of ras-Transformed Cells Back to Normal: Taxonomy, Fermentation, Isolation, Structure Elucidation and Biological Characterization
- A New 5-HT_3 Receptor Ligand. II. Structure-Activity Analysis of 5-HT_3 Receptor Agonist Action in the Gut
- Synthesis and preliminary evaluation of [1-^C]hexanoate as a PET tracer of fatty acid metabolism
- Isolation of Actinomycetes from Live Plants and Evaluation of Antiphytopathogenic Activity of Their Metabolites
- PF1163A, a Novel Antifungal Agent, Inhibit Ergosterol Biosynthesis at C-4 Sterol Methyl Oxidase
- PF1163A and B, New Antifungal Antibiotics Produces by Penicilium sp. II. Physico-chemical Properties and Structure Elucidation
- PF1163A and B, New Antifungal Antibiotics Produced by Penicilium sp. : II. Physico-chemical Properties and Structure Elucidation
- PF1163A and B, New Antifungal Antibiotics Produced by Penicillium sp. : I. Taxonomy of Producing Strain, Fermentation, Isolation and Biological Activities
- Absolute and Atropisomeric Structure of ES-242s, N-Methyl-D-aspartate Receptor Antagonists
- Synthesis on an N-Methyl-D-aspartate Receptor Antagonist, ES-242-5, and Its Analogs
- PF1092A, B and C, New Nonsteroidal Progesterone Receptor Ligands Produced by Penicillium oblatum II. Physico-chemical Properties and Structure Elucidation
- Diazaphilonic Acid, a New Azaphilone with Telomerase Inhibitory Activity
- IT-143-A and B, Novel Piericidin-group Antibiotics Produced by Streptomyces sp.
- Gualamycin, a Novel Acaricide Produced by Streptomyces sp.NK11687 II.Structural Elucidation
- Synthesis of 4'-O-Acylanthracyclines(Organic Chemistry)
- Pironetin, a Novel Plant Growth Regulator Produced by Streptomyces sp.NK10958 III.Biosynthesis
- Syntheses and Absolute Structures of the Disaccharide and Aglycone of Acaricidal Gualamycin
- Gualamycin, a Novel Acaricide Produced by Streptomyces sp.NK11687 I.Taxonomy, Production, Isolation, and Preliminary Characterization
- Watasemycins A and B, New Antibiotics Produced by Streptomyces sp. TP-A0597
- Cedarmycins A and B, New Antimicrobial Antibiotics from Streptomyces sp. TP-A0456
- TPU-0031-A and B, New Antibiotics of the Novobiocin Group Produced by Streptomyces sp. TP-A0556
- Identification of 6-Prenylindole as an Antifungal Metabolite of Streptomyces sp. TP-A0595 and Synthesis and Bioactivity of 6-Substituted Indoles
- Synthetic Studies on Oilgomycins. Synthesis of the Oligomycin B Spiroketal and Polypropionate Portions
- The First Total Synthesis of Vinaxanthone, a Fungus Metabolite Possessing Multiple Bioactivities
- Model Study for Preparation of asymmetric N, N'-Disubstituted piperazine Library:Efficient Synthesis of Aryl Piperazine and Benzyl Piperazine Derivatives on the Solid Support
- Total Synthesis of a Tetracyclic Anti-tumor, UCE6
- NK154183A and B, Antitumor Substances Produced by Streptomyces sp.
- The Total Synthesis of (±)-Coriolin
- Oxidative Modification of NK30424A and B Enhance Inhibitory Effect on Lipopolysaccharide-induced Tumour Necrosis Factor-α Promoter Activity
- NK30424A and B, Novel Inhibitors of Lipopolysaccharide-induced Tumour Necrosis Factor Alpha Production, Produced by Streptomyces sp. NA30424
- The First Total Synthesis of a Macrocyclic Anti-Protozoan, LL-Z1640-2
- The First Total Synthesis of Natural )-)-Tetracycline
- The Total Synthesis and Absolute Structure of Antifungal Antibiotics (-)-PF1163A and B
- Total Synthesis of MS-444, a Myosin Light Chain Kinase Inhibitor
- Epopromycins, Novel Cell Wall Synthesis Inhibitors of Plant Protoplast Produced by Streptomyces sp. NK 04000
- NK 10958P, a Novel Plant Growth Regulator Produced by Streptomyces sp.
- The Total Synthesis of a Glycosidase Inhibitor, Nagstatin^#
- Syntheses and Glycosidase Inhibiting Activities of Nagstatin Analogs
- Suppression of Gingival Inflammation Induced by Porphyromonas gingivalis in Rats by Leupeptic
- The First Total Synthesis of a Pyranonaphthoquinone Antitumor, BE-54238B
- PB181 THE SYNTHESIS OF OLEANDOMYCIN THROUGH THE POLYKETIDE LACTONE BY BIO-ORGANIC METHODS
- A New Approach to 5-Hydroxyindoles from 1, 4-Cyclohexanedione
- Annulation of Ethyl [Bis(ethylthio)methyl]benzoate and Ethyl 2-[1,3]Dithiolan-2-yl-benzoate with α, β-Unsaturated Carbonyl Compounds : A New Synthesis of Naphthalene and Anthracene Derivatives
- Structure-activity Relationships of Xanthocillin Derivatives as Thrombopoietin Receptor Agonist
- The First Total Synthesis of (±)-Napyradiomycin A1
- Novel Synthesis of Natural Pseudo-aminosugars, (+)-Valienamine and (+)-Validamine
- The First Total Synthesis of Natural (+)-Terpestacin, Syncytium Formation Ihibitor
- Short and Convergent Synthesis of Asterriquinone B1 and Demethylasterriquinone B1
- Synthesis and Biological Evaluation of the Analogs of Bioxanthracenes ES-242s, N-Methyl-D-aspartate Antagonists
- Biomimetic Total Synthesis of Quinolactacin B, TNF Production Inhibitor, and Its Analogs
- Novel Synthesis and Structural Elucidation of Quinolone Antibiotics PC-3 (SF2420B) and YM-30059
- The First Total Synthesis of Pyralomicin 1c
- The First Total Synthesis of Cochleamycin A and Determination of the Absolute Structure
- Novel Synthesis of (+)-4-Acetoxy-3-hydroxyethyl-2-azetidinone from Carbohydrate A Formal Total Synthesis of (+)-Thienamycin
- Total synthesis of aminoglycoside antibiotics, apramycin and saccharocin (KA-5685).
- Enantiodivergent total syntheses of nanaomycins and their enantiomers, kalafungins.
- Stereoselective syntheses of 1,3,5-trihydroxy-2,4-dimethylpentane equivalents from methyl .ALPHA.-mannopyranosides.
- Total synthesis of a macrocyclic lactone antibiotic A26771B and its isomers using carbohydrates.
- A novel synthesis of a branched-chain amino sugar, methyl 2-amino-2,3-dideoxy-3-C-formyl-.ALPHA.-D-xylofuranoside-3'R,5-hemiacetal.
- Synthetic studies of rifamycins. III. The partial synthesis of rifamycin ansa-chain compounds from their degradation products.
- Synthetic studies of rifamycins. IV. The synthesis of rifamycin ansa-chain compound using carbohydrate.
- Total synthesis of elaiophylin (azalomycin B).
- Stereoselective syntheses of 2-deoxy-.BETA.-C-arabino- and ribopyranosides: 2-Deoxy-.BETA.-arabino- and ribopyranosyl cyanides.
- Synthesis of novel lincomycin derivatives and their in vitro antibacterial activities